Research offers new approach to nongenetic T-cell-based immunotherapy

by WileyCredit: WileyImmunotherapies for cancer aim to induce the immune system to combat cancer cells more effectively. In the journalAngewandte Chemie International Edition, a Chinese res

Updated on: January 30,2024

Research offers new approach to nongenetic T-cell-based immunotherapy

by WileyCredit: WileyImmunotherapies for cancer aim to induce the immune system to combat cancer cells more effectively. In the journalAngewandte Chemie International Edition, a Chinese res

Updated on:January 30,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on: March 30,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on:March 30,2024

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study

byWellcome Trust Sanger InstitutePIK3CA mutant clones in human esophageal epithelium. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01891-8A common diabetes medication, metfo

Updated on: September 28,2024

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study

byWellcome Trust Sanger InstitutePIK3CA mutant clones in human esophageal epithelium. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01891-8A common diabetes medication, metfo

Updated on:September 28,2024

Researchers discover how malignant melanoma eludes immune cells

by Alan Dove,Columbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.014Malignant melanoma, a dangerous type of skin cancer, deploys an elegan

Updated on: February 03,2024

Researchers discover how malignant melanoma eludes immune cells

by Alan Dove,Columbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.014Malignant melanoma, a dangerous type of skin cancer, deploys an elegan

Updated on:February 03,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainIn cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce

Updated on: January 16,2024

Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainIn cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce

Updated on:January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on: January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on:January 16,2024

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Updated on: January 02,2024

Immune targets for chemotherapy-resistant breast cancers identified

byKing's College LondonAnalysis of stromal TILs in residual disease and prognostic implications. A) Kaplan–Meier curves for i) progression free survival and ii) overall survival in ER+HER2-

Updated on:January 02,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on: January 29,2024

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on:January 29,2024

Researchers find genetic pathways to individualized treatment for advanced prostate cancer

by Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced pros

Updated on: June 15,2024

Researchers find genetic pathways to individualized treatment for advanced prostate cancer

by Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced pros

Updated on:June 15,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on: January 12,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on:January 12,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024